EUVIMEDEUVIMED entdecken
Crossref

Quality Plus Quantity: Evaluation of a Virtual GLP ‐1 Programme With Physical Activity Support to Promote Healthy Body Composition Change During GLP ‐1 Weight Loss

Lisa A Stanton iD, Jeanean B Naqvi, Susan M Devaraj, Amanda McGuill, Todd Norwood, Sarah Linke

Diabetes, Obesity and Metabolism · 2026-11 · 28 (11) · 10636-10647

DOI: 10.1111/dom.71152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 01.09.2026. Verfasst von Lisa A Stanton und 5 weiteren Autor:innen. Beteiligte Einrichtung: Omada Health Inc., San Francisco, California, USA. Hauptthemen laut MEDLINE: Weight Loss, Body Composition, Obesity, Exercise. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Omada Health Inc. (Dallas, TX, USA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Glucagon‐like peptide‐1 (GLP‐1) receptor agonists can produce rapid weight loss, but this loss is frequently accompanied by disproportionate loss of lean mass, particularly during the early phase of GLP‐1‐treatment. Physical activity (PA), particularly resistance training, is the most effective behavioural strategy for enhancing fat reduction while preserving lean mass. Our primary aim was to evaluate whether a 12‐week virtual GLP‐1 lifestyle companion programme that includes PA coaching was associated with increased weight and fat loss coupled with preservation of muscle mass among adults with obesity who initiated GLP‐1 therapy for weight loss ≤ 8 weeks prior to baseline. Materials and Methods In this quasi‐experimental trial, 245 adults (151 intervention and 94 control) received either a virtual GLP‐1 lifestyle companion programme with personalised, strength‐focused PA coaching or usual care. Body composition was captured using home bioelectrical impedance analysis scales. Primary outcomes were 12‐week between‐group differences in change in weight, percent body fat and percent muscle mass.

Results

Participants in the GLP‐1 lifestyle companion programme lost an adjusted mean of 6.0% of their baseline body weight versus 3.3% in the control group (between‐group difference 2.8%, p < 0.001). Compared with controls, they also experienced a larger decline in body fat percentage (−3.3% vs. −1.6%, p < 0.001), a greater increase in muscle mass percentage (+0.6% vs. +0.2%, p < 0.01) and greater improvements in psychosocial and behavioural outcomes.

Conclusions

Personalised, virtually delivered PA programming may meaningfully improve the quantity and quality of weight loss during GLP‐1 therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Weight LossBody CompositionObesityExerciseGlucagon-Like Peptide 1Weight Reduction ProgramsHumansFemaleMaleMiddle AgedAdultTreatment Outcome

Stichwörter der Autor:innen

GLP‐1antiobesity drugcohort studyeffectivenessexercise interventionobesity care

Substanzen

Glucagon-Like Peptide 1

Autor:innen und Institutionen

  • Omada Health Inc., San Francisco, California, USA.

ORCID-Profile: Lisa A Stanton

Förderung

  • Omada Health Inc. (Dallas, TX, USA)

Zitieren

APA

Stanton, L. A., Naqvi, J. B., Devaraj, S. M., McGuill, A., Norwood, T., & Linke, S. (2026). Quality Plus Quantity: Evaluation of a Virtual GLP ‐1 Programme With Physical Activity Support to Promote Healthy Body Composition Change During GLP ‐1 Weight Loss. Diabetes, Obesity and Metabolism, 28(11), 10636-10647. https://doi.org/10.1111/dom.71152

Vancouver

Stanton LA, Naqvi JB, Devaraj SM, McGuill A, Norwood T, Linke S. Quality Plus Quantity: Evaluation of a Virtual GLP ‐1 Programme With Physical Activity Support to Promote Healthy Body Composition Change During GLP ‐1 Weight Loss. Diabetes, Obesity and Metabolism. 2026;28(11):10636-10647. doi:10.1111/dom.71152

BibTeX
@article{Stanton2026,
  author = {Stanton, Lisa A and Naqvi, Jeanean B and Devaraj, Susan M and McGuill, Amanda and Norwood, Todd and Linke, Sarah},
  title = {Quality Plus Quantity: Evaluation of a Virtual GLP ‐1 Programme With Physical Activity Support to Promote Healthy Body Composition Change During GLP ‐1 Weight Loss},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {11},
  pages = {10636--10647},
  doi = {10.1111/dom.71152}
}
Kostenlos starten →